Indaptus Therapeutics Indaptus Therapeutics. is a biopharmaceutical company that specializes in cancer and other infectious disease treatment solutions. | ![]() OnCusp Therapeutics OnCusp Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions. | ![]() ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. | |||
Founding Date | Founding Date 2018 | Founding Date 2021 | Founding Date 2021 | Founding Date 2018 | Founding Date 2003 |
Type | Type Private | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Oxford, GB HQ London, GB | Locations HQ | Locations New York, US HQ Shanghai, CN Shanghai, CN | Locations Waltham, US HQ Shanghai, CN Boston, US | Locations Athens, US HQ Athens, US |
Employees | Employees 582% increase | Employees N/A | Employees 2519% increase | Employees 8 | Employees 274% increase |
Funding | |||||
Latest funding round | Latest funding round $ 30m (over 7 years ago) | Latest funding round N/A | Latest funding round $ 100m (over 2 years ago) | Latest funding round $ 80m (almost 7 years ago) | Latest funding round $ 4.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 30m | Total funding raised N/A | Total funding raised $ 125m | Total funding raised $ 96.5m | Total funding raised $ 26.9m |
Indaptus Therapeutics. is a biopharmaceutical company that specializes in cancer and other infectious disease treatment solutions.
View company
OnCusp Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions.
View company
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
View company